Qty	Catalogue Number	Ordering Description	Qty/Pack	List Price
			96-Well Plate

Qty	Catalogue Number	Ordering Description	Qty/Pack	List Price
	48-602MAG	Buffer Detection Kit for Magnetic Beads	1 Kit

AGX841 Sigma-AldrichRecombinant SARS-CoV-2 Nucleocapsid Protein（fragment）

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.

AGX841

1 mg

Price could not be retrieved

Minimum Quantity is a multiple of

Maximum Quantity is

Upon Order Completion

You Saved ()

—

Request Pricing

—

In Stock

Discontinued

Limited Quantities Available

Availability to be confirmed

Remaining : Will advise

Will advise

Quantity:

Description
Catalogue Number	AGX841
Description	Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）
Alternate Names	Severe acute respiratory syndrome coronavirus 2 2019-nCoV
Background Information	Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Product Information
Format	Purified
Presentation	Purified recombinant protein in 0.01M PBS, pH7.4
Quality Level	MQ100

Applications
Application	This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.
Key Applications	ELISA

Biological Information
Clone	N/A
Concentration	Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Host	E. coli
Specificity	SARS CoV2
Purification Method	ni-sepharose
UniProt Number	P0DTC9

Product Usage Statements
Usage Statement	Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Storage and Shipping Information
Storage Conditions	Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.

Packaging Information
Material Size	1 mg

Global Trade Item Number
Catalogue Number	GTIN
AGX841	04061842443543

Title	Lot Number
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3802602	3802602
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3842809	3842809
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3852787	3852787
Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - 3671754	3671754
Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - Q3471655	Q3471655

Select A Species	.
Select A Panel Type	.
Select A Kit	.
Select A Sample Type	For some panels, sample type will determine which analytes can be plexed together.

PRODUCTS Products by Application Products by Brand Products by Industry Products by Type Ordering our Products	SUPPORT Help Feedback Cookies Customer & Tech Service FAQ Patents Contact Us	COMPANY About Us News Events Careers Change Country or Region	Research. Development. Production. We are a leading supplier to the global Life Science industry: solutions and services for research, development and production of biotechnology and pharmaceutical drug therapies.


Merck Group Imprint Terms of Use Privacy Statement Conditions of Sale

© 2025 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.Cookie Settings